#NATA26 | 29 April–2 May | Bilbao🇪🇸
PBM Implementation Workshop
Practical strategies to implement & sustain #PBM programmes:
• #Anaemia management
• (Anti-) #coagulation
• PBM in practice
Interactive round tables+ real-world case discussion
Registration
👉 nataonline.com/annual-sympo...
NATA26 | Bilbao 🇪🇸 | 29 April–2 May
⏰Final hours to register at the Early Bird rate.
🩸Don’t miss out on the reduced fees.
👉 Register now
nataonline.com/annual-sympo...
#PBM #transfusion #thrombosis #haemostasis #iron #coagulation #medicaleducation #anesthesia #surgery #bloodbanker
Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
This study demonstrates that #CoagulationMarkers - TAT, tPAIC, PIC, & #PlateletCount are significantly linked to #Mortality, underscoring the importance of maintaining balance between #Coagulation & #Fibrinolysis. #medsky
To read: doi.org/10.1007/s115...
Power your studies with Human & Mouse Plasma + Serum from Innovative Research
🩸Perfect for #coagulation complement #cardiovascular & #inflammation research
High purity, consistent performance
Explore more➡️ www.stratech.co.uk/our-partners...
#plasma #serum #biomarkers #assays #immunology
A new point-of-care platform is gaining attention as a promising tool to improve #coagulation testing for people with #hemophilia A. From @rarediseaseadvisor.bsky.social.
https://bit.ly/462BmXm
#HemOnc
NATA26 I 29 April-2May I Bilbao🇪🇸
Early-career in #PBM?
#NATA26 is where science, practice, and collaboration meet
Your🎓Young NATA Scholarship deadline is TOMORROW (26 Jan)
Go for it 👇
nataonline.com/annual-sympo...
#YoungNATA #Scholarship #thrombosis #haemostasis #coagulation
Abstract deadline TOMORROW (26 Jan).
#NATA26 connects clinicians and researchers advancing #PBM, #haemostasis, and #thrombosis.
Present in Bilbao. Published in @RPTH journal.
Shape the future of PBM at #NATA26
👉 nataonline.com/annual-sympo...
#ClinicalResearch #anemia #coagulation
[Open Access]
Coagulation testing method using magnetic nanoparticles
2025 Jpn. J. Appl. Phys. 64 020902
iopscience.iop.org/article/10.3...
#JJAP
#physics
#Openaccess
#magnetic
#nanoparticle
#material
#blood
#coagulation
#susceptibility
This approach moves #coagulation testing upstream, capturing the earliest “spark” of clot formation and enabling more precise, personalized assessment of clotting risk, #anticoagulant effects, disease-specific disruptions in coagulation #biology.
www.linkedin.com/posts/drmelv...
It’s exciting to witness and be part of another exceptional #viscoelastic testing platform making its mark on the market.
#MultiClot from APIRO Diagnostics Kft. represents the collective efforts and dedication of clinical users and experts throughout the years #coagulation #haemostasis
🚨📢10 more days to be part of #NATA26
🗓 New deadline: 26 January
Present your research. Advance #PBM worldwide.
✔️ Share your work with international experts
✔️ Compete for Best #Abstract
✔️ Young NATA #Scholarships available
🔗 nataonline.com/annual-sympo...
#anaemia #coagulation
#Abstracts received from across the world — and a strong #NATA26 programme is taking shape.
⏳ Abstract deadline: 16 Jan | 23:59 CET
📍 Bilbao | 29 Apr–2 May 2026
Don’t miss the chance to contribute 👉
nataonline.com/annual-sympo...
#PBM #Haemostasis #Thrombosis #anaemia #coagulation
NATA26 | 29 April - 2 May I Bilbao🇪🇸
Meet. Learn. Transform PBM.
Join global #PBM leaders in Bilbao this April!
✅ Register & book hotels
✅ Submit your abstract
nataonline.com/annual-sympo...
#thrombosis #haemostatis #coagulation #transfusion #science #pbmimplementation
🍇 ¡Feliz Año Nuevo! 🍇
In Spain, 12 grapes at midnight bring luck for the year ahead.
As 2026 begins, we look forward to welcoming you to #NATA26 in #Bilbao 🇪🇸
29 April–02 May 2026
🔗 nataonline.com/annual-sympo...
#PBM #hemostasis #thrombosis #coagulation #anemia #implementation
Red Matters: A Special Holiday Edition
17 Dec | 18:30–19:30 CET
Why do redheads bleed differently?
How do red cells influence performance?
What does red mean in art and culture?
A fun (but serious!) scientific close to the year
🟥👩🦰🧑🦰🖌️ nataonline.com/monthly-live...
#PBM #coagulation
#NATA26 I Bilbao🇪🇸I 29 April - 2 May
Only 1 month left to submit your NATA26 abstract!
Make your work seen by 600 peers & leading international experts🌍, spark discussions, & get published in #RPTH
Start today 👉 nataonline.com/annual-sympo...
#PBM #anemia #Coagulation #transfusion
Today's second question focuses on the genetic mechanism leading to low factor VIII levels and bleeding in female carriers of Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
Today’s first question focuses on the genetic mechanism underlying unexpected severe bleeding in an infant with no maternal bleeding history.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
Facts about Hemophilia A: Inhibitors and Immune Complications, and Future Directions
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social
The second question of the day!
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @ash.edu.hematology.org
Today's first question!
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Facts about Hemophilia A: Rebalancing and RNA-Based Therapies
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
The second question of the day focuses on understanding complications in patients receiving fitusiran prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Today’s first question focuses on why a child on regular recombinant Factor VIII prophylaxis may still experience several bleeding episodes each year.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab
Facts about Hemophilia A: Non-Factor (Substitution) Therapies
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
NATA26🇪🇸I 29 April-02 May
Your research can change practice.
Your ideas can shape PBM.
Your work belongs in #Bilbao.
Abstracts for #NATA26 now open
🔗 nataonline.com/annual-sympo...
#PBM #anemia #coagulation #iron #transfusion #hemostasis #medicalresearch
Today’s question focuses on the type of viral vector most commonly used in gene therapy trials for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Today’s question focuses on safe management of breakthrough bleeding in a patient receiving emicizumab prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Facts about Hemophilia A:
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Today’s question focuses on the expected laboratory pattern in a child with Hemophilia A who presents with bleeding after missing a prophylactic infusion.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
